Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial (Q80761694)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2007
edit
Language Label Description Also known as
English
Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial
scientific article published on 01 January 2007

    Statements

    title
    Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17684471
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17684471%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 January 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80761694&oldid=1613819040"